Targeted drugs for treating cervical cancer

Cervical cancer is one of the three major gynecological malignant tumors, seriously affecting women's health. In recent years, the incidence trend tends to be younger. For cervical cancer treatment, surgery is still the main treatment at this stage, combined with radiotherapy and chemotherapy. However, for cervical cancer patients, targeted drugs can also be selected for treatment. Commonly used targeted drugs can be selected amlotinib, nivolumab or pembrolizumab. These targeted drugs, to a certain extent, can significantly improve the prognosis of patients, improve the patient's life treatment, extend the life time of 5 years, for the patient recovery is a great help. Therefore, for patients with indications can choose to use targeted drugs to treat. The above plan is for reference only. Please use specific drugs under the guidance of professional doctors.